Birmingham, MI, United States of America

Jonathan S Hott


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Jonathan S. Hott

Introduction

Jonathan S. Hott is an accomplished inventor based in Birmingham, MI (US). He has made significant contributions to the field of medical science, particularly in the treatment of focal movement disorders. His innovative work has led to the development of a unique immunotoxin that has the potential to improve the quality of life for many patients suffering from muscle spasms.

Latest Patents

Jonathan S. Hott holds a patent for an immunotoxin known as mAB-RICIN, which is designed for the treatment of focal movement disorders. This patent encompasses compositions and methods for treating focal muscle spasms. The immunotoxin conjugates consist of a toxin that is conjugated to an antibody that is reactive to a muscle-specific antigen. This innovative approach represents a significant advancement in therapeutic options for patients.

Career Highlights

Hott is associated with the United States of America, as represented by the Secretary, Department of Health and Human Services. His work in this esteemed organization has allowed him to focus on groundbreaking research and development in the medical field. His dedication to improving patient outcomes through innovative treatments is commendable.

Collaborations

Throughout his career, Jonathan has collaborated with notable professionals in the field, including Richard J. Youle and Mark Hallett. These collaborations have fostered an environment of innovation and have contributed to the advancement of medical treatments.

Conclusion

Jonathan S. Hott's contributions to the field of medical science through his patent on immunotoxin for the treatment of focal movement disorders highlight his commitment to innovation. His work continues to pave the way for new therapeutic options that can significantly benefit patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…